Business Context and Reporting Period
Company: Spruce Biosciences, Inc. (SPRB)
Filing Type: Form 8-K (Current Report)
Date of Report: May 6, 2025
Reporting Period: First Quarter ended March 31, 2025
Trading Status: The registrant's common stock began trading exclusively on the OTC Pink Marketplace on April 29, 2025, under the symbol "SPRB".
Key Financial Metrics
The filing serves as a notification of a press release (Exhibit 99.1) containing financial results. The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the incorporated press release for these details.
Material Changes
- Trading Venue Change: The company's common stock moved to exclusive trading on the OTC Pink Marketplace as of April 29, 2025.
- Financial Results: The company announced Q1 2025 results and corporate updates, though specific comparative metrics are not detailed in this summary document.
Guidance, Outlook, and Risks
The filing references corporate updates and financial results but does not contain specific text regarding forward-looking guidance, management commentary, risks, or contingencies within the body of the 8-K. These items are contained within the press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2025 revenue, net loss, and cash burn figures.
- Verify the implications of the stock trading exclusively on the OTC Pink Marketplace on liquidity and market access.
- Confirm the details of the "corporate updates" mentioned in the press release for potential operational shifts.
- Check for any updated liquidity runway or financing plans disclosed in the full press release.